Similar Items: Targeting cancer stem cells: advances in small molecules, biologics, and immunotherapies
- Synergistic efficacy of radiotherapy and immunotherapy enhances clinical outcomes in patients with advanced non-small cell lung cancer
- Engineered immune cells and extracellular vesicles target tumour microenvironment barriers in solid tumour immunotherapy
- miR-34a-5p-mediated inhibition on the KRT5/DSP axis blunts cancer stem cell properties and cisplatin resistance in non-small cell lung cancer
- Dissecting liver cancer stem cell heterogeneity via single-cell RNA sequencing and developing a stemness-based prognostic model
- Identification of FMR1 as a novel cancer prognostic and immunotherapy biomarker through renal cancer experimental validation and pan-cancer analysis
- The role of HBV in reprogramming liver cancer stem cells and shaping their plasticity and therapeutic vulnerabilities